Abstract:BACKGROUND: Previous studies have shown that transforming growth factor-beta 1 (TGF-beta 1) is the most potent means of stimulating liver fibrogenesis by myofibroblast-like cells derived from hepatic stellate cells. Thus, TGF-beta 1 could be a target for treating hepatic fibrosis. This study aimed to investigate the inhibitory effects of specific TGF-beta 1 small interference RNA (siRNA) on immune hepatic fibrosis induced by Concanavalin A (Con A) in mice. METHODS: Three short hairpin RNAs targeting different positions of TGF-beta 1 were designed and cloned to the plasmid pGenesil-1 to obtain three recombinant expression vectors (pGenesil-TGF-beta 1-ml, pGenesil-TGF-beta 1-m2 and pGenesil-TGF-beta 1-m3). Thirty male Kunming mice were randomly divided into 6 groups: normal, model, control, and three treatment groups. The immune hepatic fibrosis models were constructed by injecting Con A via the tail vein at 8 mg/kg per week for 6 weeks. At weeks 2, 4 and 6, pGenesil-TGF-beta 1-ml, pGenesil-TGF-beta 1-m2 or pGenesi1-TGF-beta 1-m3 was injected by a hydrodynamics-based transfection method via the tail vein at 0.8 ml/10 g within 24 hours after injection of Con A in each of the three treatment groups. The mice in the control group were injected with control plasmid pGenesil-HK at the same dose. All mice were sacrificed at week 7. The levels of hydroxyproline in liver tissue were determined by biochemistry. Liver histopathology was assessed by Van Gieson staining. The expression levels and localization of TGF-beta 1, Smad3, and Smad7 in liver tissue were detected by immunohistochemistry. The expression of TGF-beta 1, Smad3, Smad7 and alpha-smooth muscle actin (alpha-SMA) mRNAs in the liver were assessed by semi-quantitative RT-PCR. RESULTS: The levels of hydroxyproline in the liver tissue of the treatment groups were lower than those of the model group (P<0.01). Histopathologic assay showed that liver fibrogenesis was clearly improved in the treatment groups compared with the model group. The expression levels of TGF-beta 1 and Smad3 of liver tissue were also markedly lower in the treatment groups than in the model group (P<0.01), while the levels of Smad7 were higher in the treatment groups than in the model group (P<0.01). RT-PCR further showed that the expression of TGF-beta 1, Smad3 and alpha-SMA mRNA was significantly inhibited in the treatment groups compared with the model group, while the levels of Smad7 were increased. There was no difference in the above parameters among the three treatment groups or between the control and model groups (P>0.05), but the inhibitory effect of pGenesil-TGF-beta 1-ml was the highest among the treatment groups. CONCLUSIONS: Specific siRNA targeting of TGF-beta 1 markedly inhibited the fibrogenesis of immune hepatic fibrosis induced by Con A in mice. The anti-fibrosis mechanisms of siRNAs may be associated with the down-regulation of TGF-beta 1, Smad3 and alpha-SMA expression and up-regulation of Smad7 expression in liver tissue, which resulted in suppressing the activation of hepatic stellate cells. (Hepatobiliary Pancreat Dis Int 2009; 8: 300-308)

Effects of siRNA targeting transforming growth factorβ1 on biological characteristics of rat hepatic satellite cells

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

Effect of silencing connective tissue growth factor by small interfering RNA on culture-activated rat hepatic stellate cells

The Effect of TGF-β1 siRNA on Smad3 、Smad7 mRNA Expression in the Hepatic Stellate Cells

Effects of Silencing Connective Tissue Growth Factor on Rat Transforming Growth Factor Beta/smads Signal

Effect of interfering RNA targeting high mobility group box chromosomal protein 1 on the biological characters of hepatic stellate cells

RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.

ShRNA Targeted to Rat Smad3 Decreases the Profibrosis Role of TGFβ1 in HSC - T6 Cells

Effects of Antisense Transforming Growth Factor Β Receptor-ⅰ Expressing Plasmid on Rat Activated Hepatic Stellate Cells in Vitro

The effect of interfering RNA targeting β-Catenin on the type Ⅰ and Ⅲ collagen in hepatic stellate cells

Effect of transfecting anti-TGF-β1 siRNA on TGF-β/Smad signal transmission pathway in the liver cells by different hepatic targeting methods

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

Effect of Small Interfering RNA Targeting Connective Tissue Growth Factor on the Synthesis and Secretion of Extracellular Matrix in Hepatic Stellate Cells

Inhibition effect on TGFβRⅡ expression by TGFβRⅡ-siRNA expression vector in hepatic stellate cells

Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.

Effect of Smad4 siRNA on transforming growth factor-beta-induced-type Ⅰ collagen expression

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells

Effect of interfering RNA targeting β-Catenin on the proliferation and apoptosis of hepatic stellate cells in vitro

Inhibition of TGF-β by siRNA Suppresses the Motility and Invasiveness of T24 Bladder Cancer Cells

Regulation of Hepatic Stellate Cell Activation and Proliferation by Hedgehog Signal Pathway